Open access
Open access
Powered by Google Translator Translator

Covid-19

Perspective | Were bivalent boosters worth it? The biggest questions about the newest Covid-19 vaccines are still unanswered

27 Jan, 2023 | 12:19h | UTC

Were bivalent boosters worth it? The biggest questions about the newest Covid-19 vaccines are still unanswered – Vox

 


SR | Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease

26 Jan, 2023 | 12:47h | UTC

Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression – The Lancet Infectious Diseases

Editorial: The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era – The Lancet Infectious Diseases

News Release: University of Calgary and WHO researchers find hybrid immunity is the best protection against COVID-19

Commentaries:

Review finds hybrid immunity provides best protection against Omicron – CIDRAP

Hybrid Immunity Protects Better Against Hospitalisation and Severe COVID Infection – Health Policy Watch

 


Review | Spotlight on vaccine-induced thrombosis and thrombocytopenia (VITT)

26 Jan, 2023 | 12:46h | UTC

Spotlight on vaccine-induced thrombosis and thrombocytopenia (VITT) – Blood

 


M-A | Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years

25 Jan, 2023 | 11:26h | UTC

Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis – JAMA Pediatrics

Editorial: COVID-19 Vaccines in Young Children—Reassuring Evidence for Parents – JAMA Pediatrics

 


Recommendations for the diagnosis and management of COVID-19 associated bacterial and fungal infections

20 Jan, 2023 | 14:48h | UTC

Recommendations and guidelines for the diagnosis and management of Coronavirus Disease-19 (COVID-19) associated bacterial and fungal infections in Taiwan – Journal of Microbiology, Immunology and Infection

 


Study shows low diagnostic sensitivities of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the omicron period

19 Jan, 2023 | 14:23h | UTC

Diagnostic accuracy of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the omicron period: a cross-sectional study – Clinical Microbiology and Infection

Commentary: Study: COVID-19 rapid home tests not highly sensitive for Omicron – CIDRAP

 


Cohort Study | Analysis of Rituximab use and COVID-19 hospitalization or death in patients with multiple sclerosis

19 Jan, 2023 | 14:22h | UTC

Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis – JAMA Network Open

 

Commentary on Twitter

 


Report | The COVID-19 pandemic and the future of telemedicine

18 Jan, 2023 | 14:28h | UTC

The COVID-19 Pandemic and the Future of Telemedicine – Organisation for Economic Co-operation and Development

News Release: New report looks to the future of telemedicine – Imperial College London

 


M-A | Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection

18 Jan, 2023 | 14:27h | UTC

Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis – BMJ Global Health

News Release: COVID-19 infection at any time during pregnancy boosts mother’s risk of death – BMJ

Commentary: Getting COVID in Pregnancy Greatly Raises a Woman’s Odds for Death – HealthDay

 


M-A | Increased risk of acute myocardial infarction after COVID-19 recovery

17 Jan, 2023 | 13:22h | UTC

Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis – International Journal of Cardiology

 


Impact of SARS-CoV-2 variants on inpatient clinical outcome

17 Jan, 2023 | 13:21h | UTC

Impact of SARS-CoV-2 variants on inpatient clinical outcome – Clinical Infectious Diseases

 


WHO updates COVID-19 guidelines on masks, treatments and patient care

15 Jan, 2023 | 20:44h | UTC

WHO updates COVID-19 guidelines on masks, treatments and patient care – World Health Organization

WHO Updated Guidelines:

Infection prevention and control in the context of coronavirus disease (COVID-19): a living guideline, 13 January 2023 – World Health Organization

Clinical management of COVID-19: Living guideline, 13 January 2023 – World Health Organization – World Health Organization

Therapeutics and COVID-19: Living guideline, 13 January 2023 – World Health Organization

 


RCT | Fluvoxamine no better than placebo in outpatients with mild to moderate COVID-19

15 Jan, 2023 | 20:37h | UTC

Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial – JAMA

Editorial: Lack of Benefit of Fluvoxamine for COVID-19 – JAMA

Author Interview: Fluvoxamine vs Placebo and Time to Sustained Recovery From Mild or Moderate COVID-19 – JAMA

Commentary: Trial finds that fluvoxamine doesn’t speed COVID recovery – CIDRAP

 

Commentary on Twitter

 


Review | Long COVID: major findings, mechanisms and recommendations

15 Jan, 2023 | 20:34h | UTC

Long COVID: major findings, mechanisms and recommendations – Nature Reviews Microbiology

Related: Retrospective Study | Most patients with long Covid developed after mild infection get better within a year

 


A survey of COVID-19 vaccine acceptance across 23 countries in 2022

15 Jan, 2023 | 20:33h | UTC

A survey of COVID-19 vaccine acceptance across 23 countries in 2022 – Nature Medicine

News Release: Global COVID-19 vaccine acceptance rising but hesitancy remains – London School of Hygiene & Tropical Medicine

 

Commentary on Twitter

 


Retrospective Study | Most patients with long Covid developed after mild infection get better within a year

13 Jan, 2023 | 13:42h | UTC

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study – The BMJ

News Release: Most long COVID effects resolve within a year after mild infection, finds study- British Medical Journal

Commentary: Long COVID After Mild Infection? It Fades Within a Year – HealthDay

 


Study identified six clusters of patients with long COVID, with distinct profiles of phenotypic abnormalities

13 Jan, 2023 | 13:40h | UTC

Generalisable long COVID subtypes: Findings from the NIH N3C and RECOVER programmes – eBioMedicine

 


The dangers of non-randomized, observational studies: experience from the COVID-19 epidemic

12 Jan, 2023 | 13:26h | UTC

The dangers of non-randomized, observational studies: experience from the COVID-19 epidemic – Journal of Antimicrobial Chemotherapy

 


RCT | Early treatment with Molnupiravir did not reduce hospitalizations in high-risk adults with COVID-19

12 Jan, 2023 | 13:24h | UTC

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial – The Lancet

Commentaries: 

Molnupiravir does not reduce COVID-19 hospitalisations or deaths in vaccinated, high risk people – National Institute for Health and Care Research

Molnupiravir doesn’t cut Omicron hospitalization, death but can speed recovery – CIDRAP

 


Statement | Pre-procedure and pre-admission COVID-19 testing no longer recommended for asymptomatic patients

11 Jan, 2023 | 14:36h | UTC

News Release: Pre-Procedure and Pre-Admission COVID-19 Testing No Longer Recommended for Asymptomatic Patients – Infection Control & Hospital Epidemiology

Recommendation Statement: Asymptomatic screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) as an infection prevention measure in healthcare facilities: Challenges and considerations – Infection Control & Hospital Epidemiology

Commentary: Infectious disease board recommends hospitals stop screening asymptomatic patients for Covid-19 – STAT

Related: Routine pre-operative Covid testing in elective surgeries: Is it worth it? – American Journal of Surgery

 


Circulating spike protein detected in post–COVID-19 mRNA vaccine myocarditis

11 Jan, 2023 | 14:30h | UTC

Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis – Circulation

News Release: Researchers study immune response, proteins in blood of young adults who develop rare complication after COVID vaccination – Mass General Brigham

Commentary: Free spike proteins in the blood appear to play a role in myocarditis post-COVID mRNA vaccine – News Medical

 


Review | Durability of vaccine-induced and natural immunity against COVID-19

11 Jan, 2023 | 14:29h | UTC

Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review – Infectious Diseases and Therapy

 


RCT | VV116 vs. Nirmatrelvir–Ritonavir for oral treatment of Covid-19

9 Jan, 2023 | 14:50h | UTC

VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 – New England Journal of Medicine

Commentaries: 

Study could pave way for new antiviral, as China grapples with Covid wave – STAT

Chinese oral COVID-19 drug equally effective with Paxlovid: study

VV116 Noninferior to Nirmatrelvir-Ritonavir for COVID-19 – HealthDay

 

Commentary on Twitter

 


The WHO estimates of excess mortality associated with the COVID-19 pandemic

9 Jan, 2023 | 14:48h | UTC

The WHO estimates of excess mortality associated with the COVID-19 pandemic – Nature

Commentary: Pandemic’s Two-Year Global Death Toll May Be Close to 15 Million – HealthDay

 


RCT | Twice-daily oral zinc in the treatment of patients with COVID-19.

12 Dec, 2022 | 12:48h | UTC

Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial – Clinical Infectious Diseases

 


Stay Updated in Your Specialty

No spam, just news.